Session IV: Myeloproliferative Neoplasms 

Session Chairs: John O. Mascarenhas, MD and Laura C. Michaelis, MD

ET/PV State of the Art Treatment | Gabriela Hobbs, MD | Massachusetts General Hospital, Boston, Massachusetts, USA

Targeting Anemia in MF | John O. Mascarenhas, MD | Mount Sinai Medical Center, New York, New York, USA

Mutant CALR Directed Therapies in Development | Francesco Passamonti, MD | University of Milan, Milan, Italy

JAK Inhibitor Selection/Sequence Is Nuanced in MF | Andrew Kuykendall, MD | H. Lee Moffitt Cancer Center, Tampa, Florida, USA

Cellular Therapies for MPNs | Roni Tamari, MD | Memorial Sloan Kettering Cancer Center, New York, New York, USA

Oral Abstract | TBD | Speaker | Affiliation